Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Chorzow – page 18

1 198 clinical trials in Chorzow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Chorzow at a glance
1 198
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 198 trials in Chorzow

Open in trial search

A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Placebo
  • Sponsor:Lallemand Pharma Europe filial af Lallemand Pharma AG Schweiz

A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:BeOne Medicines I GmbH

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Breast cancer+1

Recruiting

Maintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG

Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:PF-08049820
  • Sponsor:Pfizer Inc.

Asthma

Recruiting

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:KT-621
  • Sponsor:Kymera Therapeutics Inc.

Obesity+1

Recruiting

A study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Rakuten Medical Inc.

Hidradenitis

Recruiting

A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:LAD328
  • Sponsor:Almirall S.A.

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Chorzow

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on blood cancers and related conditions, including innovative treatments for multiple myeloma, lymphomas, and leukemia.

  • B-cell lymphoma treatments
  • Multiple myeloma therapies
  • Chronic lymphocytic leukemia management

Studies evaluating novel drug combinations and targeted therapies to improve patient outcomes.

02 Dermatology

Clinical research addressing various skin conditions, with particular emphasis on chronic inflammatory skin disorders and their treatment approaches.

  • Atopic dermatitis treatments
  • Vitiligo therapies
  • Acne vulgaris management

Investigating both topical and systemic treatments for enhanced therapeutic outcomes.

03 Cardiovascular Medicine

Studies exploring treatments for atherosclerotic cardiovascular disease and acute coronary syndrome, focusing on innovative therapeutic approaches.

  • Lipid-modifying therapies
  • Coronary intervention studies
  • Cardiovascular risk management

Research aimed at reducing major adverse cardiovascular events and improving patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.